MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.

MicroRNAs (miRNAs) post-transcriptionally regulate the expression of target genes, and may behave as oncogenes or tumor suppressors. Human malignant mesothelioma is an asbestos-related cancer, with poor prognosis and low median survival. Here we report, for the first time, a cross-evaluation of miRNA expression in mesothelioma (MPP-89, REN) and human mesothelial cells (HMC-telomerase reverse transcriptase). Microarray profiling, confirmed by real-time quantitative RT-PCR, revealed a differential expression of miRNAs between mesothelioma and mesothelial cells. In addition, a computational analysis combining miRNA and gene expression profiles allowed the accurate prediction of genes potentially targeted by dysregulated miRNAs. Several predicted genes belong to terms of Gene Ontology (GO) that are associated with the development and progression of mesothelioma. This suggests that miRNAs may be key players in mesothelioma oncogenesis. We further investigated miRNA expression on a panel of 24 mesothelioma specimens, representative of the three histotypes (epithelioid, biphasic, and sarcomatoid), by quantitative RT-PCR. The expression of miR-17-5p, miR-21, miR-29a, miR-30c, miR-30e-5p, miR-106a, and miR-143 was significantly associated with the histopathological subtypes. Notably, the reduced expression of two miRNAs (miR-17-5p and miR-30c) correlated with better survival of patients with sarcomatoid subtype. Our preliminary analysis points at miRNAs as potential diagnostic and prognostic markers of mesothelioma, and suggests novel tools for the therapy of this malignancy.

[1]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[2]  Martin T. Morgan,et al.  Gene Set Enrichment Analysis , 2008 .

[3]  G. Vicidomini,et al.  Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma , 2004, Thorax.

[4]  A. Hatzigeorgiou,et al.  A combined computational-experimental approach predicts human microRNA targets. , 2004, Genes & development.

[5]  C. Porta,et al.  Erionite and asbestos differently cause transformation of human mesothelial cells , 2007, International journal of cancer.

[6]  B. Christensen,et al.  Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma , 2008, Carcinogenesis.

[7]  W. Hahn,et al.  Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics , 2000, Molecular and Cellular Biology.

[8]  A. Donfrancesco,et al.  Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM , 2008, PloS one.

[9]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Fang Zhou,et al.  Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. , 2008, Cancer research.

[11]  A. Ardizzoni,et al.  Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. , 1999, The European respiratory journal.

[12]  J. Pilewski,et al.  Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. , 1994, The Annals of thoracic surgery.

[13]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[14]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[15]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[16]  A. Kane,et al.  SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells. , 2007, Cancer research.

[17]  B. Robinson,et al.  Advances in malignant mesothelioma. , 2005, The New England journal of medicine.

[18]  C. Porta,et al.  SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. , 2005, Cancer research.

[19]  J. Shamash,et al.  Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Rascoe,et al.  Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma. , 2005, The Journal of thoracic and cardiovascular surgery.

[21]  C. Harris,et al.  Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. , 2000, Cancer research.

[22]  H. Pass,et al.  TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis , 2006, Proceedings of the National Academy of Sciences.

[23]  Terry Hyslop,et al.  A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.

[24]  Robert Gentleman,et al.  Bioconductor Case Studies , 2008 .

[25]  D. Fennell,et al.  Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. , 2004, The Lancet. Oncology.

[26]  Bart N Lambrecht,et al.  Proteomic analysis of exosomes isolated from human malignant pleural effusions. , 2004, American journal of respiratory cell and molecular biology.

[27]  Chao Cheng,et al.  Inferring MicroRNA Activities by Combining Gene Expression with MicroRNA Target Prediction , 2008, PloS one.

[28]  T. Patel,et al.  The MicroRNA let-7a Modulates Interleukin-6-dependent STAT-3 Survival Signaling in Malignant Human Cholangiocytes* , 2007, Journal of Biological Chemistry.

[29]  C. Porta,et al.  Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma , 2007, Clinical Cancer Research.

[30]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[31]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[32]  C. Porta,et al.  SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Pass,et al.  A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes , 2007, Nature Reviews Cancer.

[34]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[35]  Luigi Marchionni,et al.  Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 , 2004, Oncogene.

[36]  Colin N. Dewey,et al.  A Genome-Wide Map of Conserved MicroRNA Targets in C. elegans , 2006, Current Biology.

[37]  J. Mendell.  miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.

[38]  H. Pass,et al.  Malignant pleural mesothelioma. , 1993, Current problems in surgery.